1 Start 2 Complete

After attending this session I can now demonstrate the identified learning objectives *

	Yes	No
Discuss challenges of managing anaphylaxis in public spaces such as schools, restaurants, airplanes, hospitals, and areas affected by epinephrine shortages	Discuss challenges of managing anaphylaxis in public spaces such as schools, restaurants, airplanes, hospitals, and areas affected by epinephrine shortages - Yes	Discuss challenges of managing anaphylaxis in public spaces such as schools, restaurants, airplanes, hospitals, and areas affected by epinephrine shortages - No
Discuss anaphylaxis risk with new treatments from immunotherapy to biologics	Discuss anaphylaxis risk with new treatments from immunotherapy to biologics - Yes	Discuss anaphylaxis risk with new treatments from immunotherapy to biologics - No
Discuss anaphylaxis risk in primary mast cell disorders	Discuss anaphylaxis risk in primary mast cell disorders - Yes	Discuss anaphylaxis risk in primary mast cell disorders - No

The session format and teaching technique were appropriate for the content. *

Yes

No

This session met my expectations based on the session description and learning objectives. *

Yes

No

I observed objective, balanced content that demonstrated no bias in favor of goods or services of a commercial interest. *

Yes

No

Speaker/Moderator was engaging and provided accurate, valuable content *

	Yes	No
Anil Nanda, MD FAAAAI	Anil Nanda, MD FAAAAI - Yes	Anil Nanda, MD FAAAAI - No
Julie Wang, MD FAAAAI	Julie Wang, MD FAAAAI - Yes	Julie Wang, MD FAAAAI - No
Antonella Cianferoni, MD PhD FAAAAI	Antonella Cianferoni, MD PhD FAAAAI - Yes	Antonella Cianferoni, MD PhD FAAAAI - No
Olajumoke Fadugba, MD	Olajumoke Fadugba, MD - Yes	Olajumoke Fadugba, MD - No

If you responded no to any questions, or have other comments about this session, please explain.

Please provide any additional feedback about the faculty in this session:

Leave this field blank